Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RSII ~ New FB posts of new product! High volume being traded this morning!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio
Completely agree! .05 is the minimum
$$$$ RSII
The hike in volume is amazing, and it's not even noon yet!
Big year ahead of us! .05+
We need to get the word out on the big boards. Let's all make some money here $$$$
$RSII
Wow!!! .05+ Let's Gooo!!!
Thanks, maronti!
$RSII
What's going on?!! What did I miss? GO $RSII!!!!
These shorters are blamming Ken! Funny!!!
$SDVI .01+
With the MMJ license, we are going to to fly high!!!
$RSII
.05+
Yes sir! Their time is running out.
.05+
$RSII
.02 - .03 Short term PPS IMHO
$RSII
$SDVI ~ Monster Crypto News from last week:
Signature Devices Announces Joint Venture with Genius Ventures to launch an Artificial Intelligence CryptoCurrency for GPU Media Devices
IRVINE, CA,, Jan. 18, 2018 (GLOBE NEWSWIRE) -- --Signature Devices, Inc. (OTCPK: SDVI) – today announced that it has entered into a joint venture with Genius Ventures, LLC. The two companies are launching a CryptoCurrency that will be used in Innovo Technologies GPU enabled Media devices. These types of CrytpoCurrencies are sometimes called Utility Tokens, as the currency will be used for the processing of Artificial Intelligence.
Innovo Technology, a leading software and hardware development is integrating the CryptoCurrency into the IOT business. Each device will use the idle time to execute artificial intelligence processing and receive CryptoCurrency in an internal wallet that can be used to purchase media such as Movies & Music and even redeem the CryptoCurrency for other currencies.
The agreement terms are as follows: Signature Devices, Inc. will receive 20% of the initial supply of CryptoCurrency as an asset to the company. Genius Ventures will retain another 20% of the initial supply and another 20% will go to an unannounced third party. There will be another announcement with details on the third party and Graffiti Entertainment, the subsidiary of Signature Devices, Inc. The remaining 40% of the initial supply of the CryptoCurrency will be used for an Initial Coin Offering for foreign investors that can invest in CryptoCurrencies without regulatory concerns.
The CryptoCurrency is based off of the Ethereum Blockchain and is utilizing smart contracts for the A.I. Processing and payment system. There are varied devices that will be able to earn the CryptoCurrency by utilizing the idle time of GPUs for the A.I. processing. Each device/device owner will then receive 70% of the payments for that processing.
$SDVI
Absolutely! Monster Crypto News from last week:
Signature Devices Announces Joint Venture with Genius Ventures to launch an Artificial Intelligence CryptoCurrency for GPU Media Devices
IRVINE, CA,, Jan. 18, 2018 (GLOBE NEWSWIRE) -- --Signature Devices, Inc. (OTCPK: SDVI) – today announced that it has entered into a joint venture with Genius Ventures, LLC. The two companies are launching a CryptoCurrency that will be used in Innovo Technologies GPU enabled Media devices. These types of CrytpoCurrencies are sometimes called Utility Tokens, as the currency will be used for the processing of Artificial Intelligence.
Innovo Technology, a leading software and hardware development is integrating the CryptoCurrency into the IOT business. Each device will use the idle time to execute artificial intelligence processing and receive CryptoCurrency in an internal wallet that can be used to purchase media such as Movies & Music and even redeem the CryptoCurrency for other currencies.
The agreement terms are as follows: Signature Devices, Inc. will receive 20% of the initial supply of CryptoCurrency as an asset to the company. Genius Ventures will retain another 20% of the initial supply and another 20% will go to an unannounced third party. There will be another announcement with details on the third party and Graffiti Entertainment, the subsidiary of Signature Devices, Inc. The remaining 40% of the initial supply of the CryptoCurrency will be used for an Initial Coin Offering for foreign investors that can invest in CryptoCurrencies without regulatory concerns.
The CryptoCurrency is based off of the Ethereum Blockchain and is utilizing smart contracts for the A.I. Processing and payment system. There are varied devices that will be able to earn the CryptoCurrency by utilizing the idle time of GPUs for the A.I. processing. Each device/device owner will then receive 70% of the payments for that processing.
$SDVI
Chart is looking to breakout!
$RSII
SDVI taking off!!!
$RSII ~ Primed to run HARD!!!
.05+
Thin!!! Could run to .05+ Easily! IMHO
$RSII
Flyinggg!!!! So high so high so highhh!!
$RSII
Watch it!!!! Let's go pennyland! IMMINENT
$RSII ~ Here we go!! +21%
$RSII ~ Here we go!! +16%
$RSII ~ Watch for breakout!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio
Jan 18, 2018
OTC Disclosure & News Service
-
SANDUSKY, Ohio, Jan. 18, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
“Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards,” states COO Arthur Hall.
“We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen™, a revolutionary product we’ve been developing for some time now. Cannophen™ is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD).”
Hall adds, “There has never been any proper way to dose with the above said methods. We have developed Cannophen™ using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists.”
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
“We’ve also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production,” concludes Hall.
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis”
$RSII ~ Watch for breakout!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio
Jan 18, 2018
OTC Disclosure & News Service
-
SANDUSKY, Ohio, Jan. 18, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
“Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards,” states COO Arthur Hall.
“We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen™, a revolutionary product we’ve been developing for some time now. Cannophen™ is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD).”
Hall adds, “There has never been any proper way to dose with the above said methods. We have developed Cannophen™ using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists.”
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
“We’ve also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production,” concludes Hall.
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis”
Good Morning! Let's break .001 today!!!
$SDVI
Good Morning!!!! $RSII
Agreed. We need the momentum going!
$RSII
Absolutely!
Green Friday @ $RSII?
Let's close green for the weekend!
$SDVI
$RSII has a ton going for it! I think charts play a role, but the upside potential of this company is what will truly make it run like hell!
.05+
Let's move out of trips today!
$SDVI
$SDVI taking off! Crypto news yesterday!
Signature Devices Announces Joint Venture with Genius Ventures to launch an Artificial Intelligence CryptoCurrency for GPU Media Devices
IRVINE, CA,, Jan. 18, 2018 (GLOBE NEWSWIRE) -- --Signature Devices, Inc. (OTCPK: SDVI) – today announced that it has entered into a joint venture with Genius Ventures, LLC. The two companies are launching a CryptoCurrency that will be used in Innovo Technologies GPU enabled Media devices. These types of CrytpoCurrencies are sometimes called Utility Tokens, as the currency will be used for the processing of Artificial Intelligence.
Innovo Technology, a leading software and hardware development is integrating the CryptoCurrency into the IOT business. Each device will use the idle time to execute artificial intelligence processing and receive CryptoCurrency in an internal wallet that can be used to purchase media such as Movies & Music and even redeem the CryptoCurrency for other currencies.
The agreement terms are as follows: Signature Devices, Inc. will receive 20% of the initial supply of CryptoCurrency as an asset to the company. Genius Ventures will retain another 20% of the initial supply and another 20% will go to an unannounced third party. There will be another announcement with details on the third party and Graffiti Entertainment, the subsidiary of Signature Devices, Inc. The remaining 40% of the initial supply of the CryptoCurrency will be used for an Initial Coin Offering for foreign investors that can invest in CryptoCurrencies without regulatory concerns.
The CryptoCurrency is based off of the Ethereum Blockchain and is utilizing smart contracts for the A.I. Processing and payment system. There are varied devices that will be able to earn the CryptoCurrency by utilizing the idle time of GPUs for the A.I. processing. Each device/device owner will then receive 70% of the payments for that processing.
$SDVI taking off! Crypto news yesterday!
Signature Devices Announces Joint Venture with Genius Ventures to launch an Artificial Intelligence CryptoCurrency for GPU Media Devices
IRVINE, CA,, Jan. 18, 2018 (GLOBE NEWSWIRE) -- --Signature Devices, Inc. (OTCPK: SDVI) – today announced that it has entered into a joint venture with Genius Ventures, LLC. The two companies are launching a CryptoCurrency that will be used in Innovo Technologies GPU enabled Media devices. These types of CrytpoCurrencies are sometimes called Utility Tokens, as the currency will be used for the processing of Artificial Intelligence.
Innovo Technology, a leading software and hardware development is integrating the CryptoCurrency into the IOT business. Each device will use the idle time to execute artificial intelligence processing and receive CryptoCurrency in an internal wallet that can be used to purchase media such as Movies & Music and even redeem the CryptoCurrency for other currencies.
The agreement terms are as follows: Signature Devices, Inc. will receive 20% of the initial supply of CryptoCurrency as an asset to the company. Genius Ventures will retain another 20% of the initial supply and another 20% will go to an unannounced third party. There will be another announcement with details on the third party and Graffiti Entertainment, the subsidiary of Signature Devices, Inc. The remaining 40% of the initial supply of the CryptoCurrency will be used for an Initial Coin Offering for foreign investors that can invest in CryptoCurrencies without regulatory concerns.
The CryptoCurrency is based off of the Ethereum Blockchain and is utilizing smart contracts for the A.I. Processing and payment system. There are varied devices that will be able to earn the CryptoCurrency by utilizing the idle time of GPUs for the A.I. processing. Each device/device owner will then receive 70% of the payments for that processing.
No dilution! Come on $SDVI!!! Let's go! .01+
Get the word out! Post on the big boards. We need more exposure!!
Lots of longs here, we aren't going anywhere until .05+
Need new investors!
$RSII
Ask is getting slappeddd!!!!
$RSII
$RSII - heading back to pennyland!!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio
Jan 18, 2018
OTC Disclosure & News Service
-
SANDUSKY, Ohio, Jan. 18, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
“Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards,” states COO Arthur Hall.
“We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen™, a revolutionary product we’ve been developing for some time now. Cannophen™ is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD).”
Hall adds, “There has never been any proper way to dose with the above said methods. We have developed Cannophen™ using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists.”
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
“We’ve also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production,” concludes Hall.
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis”
$RSII - ready to go back to pennyland!!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio
Jan 18, 2018
OTC Disclosure & News Service
-
SANDUSKY, Ohio, Jan. 18, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
“Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards,” states COO Arthur Hall.
“We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen™, a revolutionary product we’ve been developing for some time now. Cannophen™ is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD).”
Hall adds, “There has never been any proper way to dose with the above said methods. We have developed Cannophen™ using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists.”
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
“We’ve also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production,” concludes Hall.
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis”
Agreed! We will soon be out of trips for good!
Watch for a market price re-evaluation for $SDVI. This is a new company since Mr. Azzam has taken over. Resurrected, revived, renewed, however you want to put it!
.01+
The post on January 8, 2018 that quotes: "We are pleased to announce that a lot of good things are coming. 2018 is going to be a very good year for Rising Biosciences." is looking to be a valid opinion.
$RSII
.05+
#2 on breakout boards!
Spread the great news, folks!
$RSII